I'm still trying to figure out if the float has changed, but to clear up your post about the increase in shares from the previous 10-Q it looks like the new shares were never put into the float.
This accounts for all of the new shares (can someone possibly confirm for me as to whether or not these would be restricted shares and for how long they would be restricted)
From the February 16th 10-Q:
February 10, 2010, there were 605,400,000 shares of the issuer’s common stock
From May 13th 10-Q:
May 13th, 2010, there were 1,014,616,666 shares of the issuer’s common stock
That's an increase of 409,216,666 shares which are all accounted for here:
(Page 17)ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
We issued the following equity securities during the quarter ended March 31, 2010.
In March 2010 we issued 100,000,000 shares of common stock at $0.0006 per share (an aggregate of $60,000) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to Mr. Spalding an Officer and Director, pursuant to a
management contract.
In March 2010 we issued 50,000,000 shares of common stock at $0.0006 per share (an aggregate of $30,000) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to Mr. Harz an Officer and Director pursuant, to a
management contract.
In March 2010 we issued 50,000,000 shares of common stock at $0.0006 per share (an aggregate of $30,000) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to a company of which Mr. Campbell an Officer and
Director is an affiliate, pursuant to a management contract.
In March 2010 we issued 60,000,000 shares of common stock at $0.0006 per share (an aggregate of $36,000) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to Mr. N. Warman, pursuant to a consulting contract.
In March 2010 we issued 40,000,000 shares of common stock at $0.0006 per share (an aggregate of $24,000) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to Mr. R. Kamyszek, pursuant to a consulting contract.
In March 2010 we sold 23,216,666 shares of common stock at $0.0006 per share (an aggregate of $13,930) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to certain accredited investors in repayment of
outstanding shareholder loans
In March 2010 we sold 19,250,000 shares of common stock at $0.0006 per share (an aggregate of $11,550) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to certain accredited investors in repayment of
outstanding shareholder loans
In March 2010 we sold 10,750,000 shares of common stock at $0.0006 per share (an aggregate of $6,450) in a transaction not involving a
public offering under
Section 4(2) of the Securities Act of 1933, as amended, and Regulation D thereunder, to a creditor in repayment of an outstanding liability
The total of these shares is: 353,216,666
Which leaves 56,000,000 other shares that are account for here
In addition to the above shares, 56,000,000 shares are pending cancellation. These shares were issued and subsequently cancelled when the
merger with Ophthalmic International, Inc. was rescinded. However, the physical certificate was lost and thus it is being disclosed separately in
our share capital. The shares have legally been cancelled, but are still outstanding until the physical certificate can be surrendered to our
transfer agent. Management has placed a stop with our transfer agent and will not permit these shares to be negotiated or reissued.
There are no preferred shares outstanding. The Company has no stock option plan, warrants or other dilutive securities.
So, yes the shares did increase by about 350,000,000 but it looks like they were shares used to pay the new officers and other companies. I would just like to know then if these shares are restricted and if that is the case are they restricted for a year?
I would take that as a good sign if that is the case because obviously if the officer's shares are tied up for a year they aren't going to want to see this thing tank since that is their payment.
*** I am not trying to promote or pump this stock. I am just reposting information for the company's May 10-Q and trying to figure out if the float has remained the same. Obviously if the new shares that were issued are in fact restricted shares, that won't affect the float, and it would remain the same.
